Commodore Capital LP reports 7.6% stake in Sagimet Biosciences
- 5,507,752 shares beneficially owned
- 7.6% of class represented
- Includes pre-funded warrants
Commodore Capital LP, filed by
Every EDGAR filing for Sagimet Biosciences Inc. (SGMT), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 13 · 10-Q expected ~Nov 13 (deadline Nov 16)
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Commodore Capital LP, filed by
George Kemble, insider filing for SGMT
George Kemble, reporting
George Kemble, planned sale of SGMT shares
George Kemble, reporting
Ownership stake disclosure by BALYASNY ASSET MANAGEMENT L.P.
BALYASNY ASSET MANAGEMENT L.P., filed by
George Kemble, insider filing for SGMT
George Kemble, reporting
George Kemble, planned sale of SGMT shares
George Kemble, reporting
Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by
David Happel, insider filing for SGMT
David Happel, reporting
George Kemble, planned sale of SGMT shares
George Kemble, reporting
Beth C Seidenberg, insider filing for SGMT
Beth C Seidenberg, reporting
Thierry Chauche, insider filing for SGMT
Thierry Chauche, reporting
Andreas Grauer, insider filing for SGMT
Andreas Grauer, reporting
Elizabeth Rozek, insider filing for SGMT
Elizabeth Rozek, reporting